Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study

Yildirim, Hasan Cagri; Mutlu, Emel; Chalabiyev, Elvin; Ozen, Mirac; Keskinkilic, Merve; On, Sercan; Celebi, Abdussamet; Dursun, Bengu; Acar, Omer; Kahraman, Seda; Aykan, Musa Baris; Kaman, Omur; Dogan, Akif; Erdogan, Atike Pinar; Celayir, Ozde Melisa; Gunenc, Damla; Guven, Deniz Can; Bayoglu, Ibrahim Vedat; Yavuzsen, Tugba; Hacibekiroglu, Ilhan; Inanc, Mevlude; Kilickap, Saadettin; Yalcin, Suayib; Aksoy, Sercan

doi:10.1016/j.breast.2022.09.009

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study

Date

2022

Authors

Yildirim, Hasan Cagri

dc.identifier.doi

10.1016/j.breast.2022.09.009

dc.identifier.other

WOS:000875350600003

Publisher

CHURCHILL LIVINGSTONE

DOI

10.1016/j.breast.2022.09.009

Keywords

Male breast cancer , Palbociclib , Ribociclib

URI

https://openaccess.acibadem.edu.tr/handle/11443/6779

Collections

WOS

Full item page

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By